logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Meiyin Gene (06667.HK) spent HKD 1.0925 million on October 9 to repurchase 152,000 shares.

date
09/10/2026
Zhito Finance APP News: Meiyin Gene (06667.HK) announced that on October 9, 2026, it spent HK$1.0925 million to repurchase 152,000 shares.
Latest
1 m ago
Zhenro Properties (06158.HK) accumulated contracted sales for the first 9 months amounted to approximately RMB 3.101 billion, a year-on-year decrease of 5.69%.
3 m ago
Chaozhou Eye Ophthalmology (02219.HK) spent HKD 452,200 to repurchase 189,500 shares on October 9.
5 m ago
The 2026 Meituan Labor Rules and Algorithm Consultation Meeting was recently held in Beijing. Frontline rider representatives from across the country held consultations with the Meituan platform on topics including labor remuneration, order dispatch rules, rest and leave, and labor protection, and signed the "2026 Meituan Labor Rules and Algorithm Consultation Agreement" on site. The agreement specifies that Meituan will increase the billing weight for orders that are more difficult to deliver, such as overweight orders, large-volume orders, and orders requiring walking up and down stairs, and increase income and remuneration under special weather conditions; continue to implement "no overtime deduction for cancellations," and continuously optimize mechanisms such as on-route order dispatch, delivery time limits, and estimated merchant meal preparation times; gradually expand the "red light stopwatch" pilot; and promote the implementation of the pension insurance subsidy policy to reduce the burden on riders participating in insurance, among other measures.
6 m ago
Yaozhi Bang (09885.HK) spent approximately HKD 223,000 on October 9 to repurchase 65,600 shares.
6 m ago
Shanghai Pharmaceuticals (02607.HK): Clevidipine Emulsion Injection Approved for Production
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.